| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Aryeh Jason is a Director at OBIO with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $16.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2016 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 6,129 | $101.18 | $620,139.89 | -1.3% | |
| Nov 11, 2015 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 3,000 | $101.49 | $304,470.00 | -1.2% | |
| Jun 4, 2015 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 1,640 | $92.68 | $151,995.20 | -0.7% | |
| May 20, 2015 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 9,240 | $87.34 | $807,046.80 | -1.2% |